Introduction
Activated platelets facilitate coagulation (platelet procoagulant activity, PPA) mainly by exposing the procoagulant phospholipid phosphatidylserine (PS) on the outer membrane surfaces and releasing PS-expressed microvesicles (MVs) [1] [2] [3] [4] [5] [6] . Exposure of PS allows binding of important coagulation factors, greatly enhancing the catalytic efficiencies of coagulation enzymes 5 . However, under static conditions in vitro, platelet agonists are inefficient in inducing PS exposure, even at high concentrations that robustly cause platelet activation 5 . Even the combination of unusually high concentrations of collagen and thrombin together only induces partial platelet PS exposure 5, 7 . To resolve this discrepancy, we have recently demonstrated that efficient PS exposure and MV release not only requires agonist stimulation of platelets, but also requires flow shear force 8 . However, the mechanism responsible for the sheardependence remains unknown. Furthermore, some recent reports that partial inhibition of platelet thrombus formation using PAR4 antagonists or integrin antagonists had minimal effects on fibrin deposition in vivo raised controversy about whether platelets are important in intravascular coagulation in vivo 9, 10 . In this study, we demonstrate that platelet integrin outside-in signaling is the mechanism responsible for the role of shear force in PPA, and is important in facilitating coagulation in vitro and in vivo.
Integrins mediate cell adhesion [11] [12] [13] , and bind their ligands with a "catch bond" 14, 15 , which is resistant to pulling force such as shear. Integrins also transmit signals bidirectionally 11, 12, 16 . Inside-out signaling activates the ligand binding function of integrins [17] [18] [19] [20] . Conversely, ligand binding to integrins induces outside-in signaling For personal use only. on June 2, 2018. by guest www.bloodjournal.org From leading to a series of cellular responses including cell spreading, retraction and migration 16, 21 . In vascular endothelial cells, it has been suggested that shear stress regulates integrin activity leading to high affinity ligand binding, which conversely transmits outside-in signals important in regulating vascular integrity, tonicity, and in the development of atherosclerosis [22] [23] [24] . Thus, integrins are proposed as mechanical sensors in vascular endothelial cells, although it remains unclear whether shear stress activates ligand binding to integrins, indirectly leading to outside-in signaling, or shear stress directly induces outside-in signaling. In platelets, inside-out signaling activates the integrin αIIbβ3, which mediates platelet adhesion and aggregation. Conversely outside-in signaling mediates platelet spreading and also greatly amplifies platelet thrombi 17, [25] [26] [27] . We recently demonstrated that a G protein subunit, Gα13, directly binds to integrin β3 cytoplasmic domain 28, 29 , and this interaction is important for the activation of c-Src and Src-dependent integrin outside-in signaling [28] [29] [30] [31] [32] [33] . Here we demonstrate that Gα13-dependent integrin outside-in signaling is important for shear-dependent platelet PS exposure and MV release induced by platelet agonists. Furthermore, we demonstrate that the integrin αIIbβ3 serves as a shear sensor that, via Gα13-dependent outside-in signaling, induces PS exposure and facilitates coagulation in vitro and in vivo.
Importantly, pharmacologically targeting outside-in signaling potently inhibits both intravascular coagulation and platelet thrombi.
Methods

Animals
For personal use only. on June 2, 2018. by guest www.bloodjournal.org From Integrin β3 -/mice, PF4-Cre mice and C57BL/6 mice were obtained from the Jackson Laboratory. Gα13 fl/fl mice were gifts from Dr. Stefan Offermanns, Max-Planck-Institute for Heart and Lung Research, Germany 34 . Platelet-specific Gα13 knockout mice were generated by breeding of Gα13 fl/fl with PF4-Cre mice. Animal usage and protocol were approved by the Institutional Animal Care Committee, University of Illinois at Chicago.
Mice with similar age, weight and sex ratios (1:1) were used. For cremaster arteriolar thrombosis model, only male mice were used.
Preparation of blood cells
See Supplemental Data 35, 36 . Platelets were resuspended in modified Tyrode's buffer 37 , and allowed to rest for at least 1 hour at 22°C before use. Human subject study was approved by Institutional Review Board at the University of Illinois at Chicago and Georgia Institute of Technology. Informed consent was provided for all donors according to the Declaration of Helsinki. Donors had not taken medication within 2 weeks before donation.
Flow cytometric analysis of platelet MV release and PS exposure
Platelet MV release and PS exposure were analyzed by flow cytometry as described previously 8 . The washed platelets were stimulated with thrombin, collagen related peptide (CRP), ADP or TXA2 mimetic (U46619) for 8 minutes. Flow at defined shear rates were introduced for 8 minutes using a cone-and-plate rheometer (Thermo Scientific Haake, CT35 cone: 0.5°, 35 mm). The samples were then incubated with Alexa Fluor-488-conjugated Annexin V (Invitrogen) for PS detection, and analyzed using a flow cytometer (AccuriTM C6 flow cytometer (BD Biosciences)) and FlowJo
For personal use only. on June 2, 2018. by guest www.bloodjournal.org From software (Tree Star Inc.) as previously described 38 . The platelet MV and platelets were distinguished according to their light scattering pattern as previously described 39, 40 , and verified with anti-αIIb antibody staining.
Peptide inhibitors
Myristoylated peptides mP6 (Myr-FEEERA), the corresponding control peptides, mP6Scr (Myr-ERAFEE) and AAA (Myr-FAAARA), were synthesized and purified at the Research Resource Center at the University of Illinois at Chicago or provided by Dupage Medical Technology, Inc. Willowbrook, IL. The peptides were formulated as micellar nanoparticles as previously described 29 and in Supplemental Data.
Dual biomembrane force probe assay
In a chamber filled with modified Tyrode's buffer, two biomembrane force probes (BFP) are set up in parallel for stimulating integrin αIIbβ3 and reporting PS exposure, respectively (Supplemental data and supplemental Figure 1 ). The reporter BFP consists of a micropipette aspirated a biotinylated human red blood cell (RBC) with a glass bead coated with Annexin V and streptavidin attached onto its apex [41] [42] [43] . An opposing micropipette aspirated a platelet, and was driven by a piezoelectric translator to move forward/backward to get in/out of contact with the Annexin V bead to test for binding.
The horizontal position of the bead was tracked by a high speed camera, which reflected the RBC axial deformation. A tensile force signal following retraction of the piezo manifested a binding event, while a zero-force indicated no binding. The approach-contact-retraction cycle was repeated for 50 times for 4 platelet-bead pairs to render the average binding frequency. The stimulating BFP is similar to the reporter For personal use only. on June 2, 2018. by guest www.bloodjournal.org From BFP except that the glass bead was coated with FN. The platelet was first brought into repeated contacts and retractions with the FN beads for a period of 5 min, with an average adhesion frequency of 80% (1.6 bonds per contact on average). Then the position of the platelet was quickly (<1 min) realigned from the stimulating BFP to the reporting BFP for measurement of Annexin V binding.
Bone marrow transplantation
See Supplemental Data and description in our previous publication 28, 29 .
Recalcification time
Recalcification time of citrated PRP was the time from addition of 20 mM CaCl2 to the formation of a fibrin clot, which was monitored either in a cone-and-plate rheometer (Thermo Scientific Haake) or a turbidometric lumi-aggregometer (Chrono-Log) as described previously (see Supplemental Data) 8 .
Fluorescence intravital microscopy
Laser-induced mouse cremaster arteriolar thrombosis is performed as described previously 44 and in Supplemental Data. Platelet and fibrin accumulation around the site of injury was visualized by infusion of DyLight 649-labeled anti-mouse GPIbβ and Alexa Fluor (AF) 488-labeled monoclonal anti-fibrin antibody (clone 59D8) following laserinduced injury 45 . The laser was adjusted to be sufficient to cause vascular endothelial injury and thrombosis, but not large penetration wound to the vessel wall. Fluorescence and bright-field images were recorded by an Olympus BX61W microscope with a For personal use only. on June 2, 2018. by guest www.bloodjournal.org From 603/1.0 NA water immersion objective and a high-speed camera through an intensifier at 26/27/28 injury sites in three mice per group. The experiments were double-blinded.
Statistics
Data analysis was performed in GraphPad Prism 5. Statistical significance was assessed using the Student t test for comparison of parametric data between 2 groups, and using ANOVA for comparing ˃2 groups. Comparisons of non-parametric data from recalcification and intravital microscopy experiments were performed using Mann-Whitney test.
Results
An important role for integrin β3 in shear-dependent MV release and PS exposure in thrombin-activated platelets
To determine the role of integrin β3 in shear-dependent MV release and PS exposure, washed wild type and β3 -/platelets were stimulated with thrombin (0.05 U/mL) and subjected to defined shear rates (250-6000 s -1 ) induced by a cone-and-plate rheometer and analyzed using flow cytometry. As expected, neither wild type nor integrin β3 -/platelets generated MVs and exposed PS under various levels of shear in the absence of thrombin (Figure 1 A, C). Conversely, thrombin-stimulated platelets showed a sheardependent increase in MV release, which reached maximal at ~3000 s -1 (Figure 1 B) .
These shear rates are well below the shear rates required for GPIb-IX-dependent MV release as reported in the literature 46 . Interestingly, shear-dependent microvesiculation 
The importance of integrin β3 in shear-dependent MV release and PS exposure induced by collagen-related peptide (CRP)
To exclude the possibility that the role of integrins in shear-dependent MV release and PS exposure is restricted to the signaling pathways activated by thrombin, we also investigated the role of integrin β3 in shear-dependent MV release and PS exposure in CRP-stimulated platelets. CRP induces platelet activation via the GPVI-ITAM signaling pathway. Similar to thrombin-stimulated platelets, shear-dependent MV release and PS exposure dose-dependently increased in response to CRP in wild type but not β3 -/platelets (Figure 2 A, B) . These data indicate that integrin αIIbβ3 plays an important role in shear-dependent MV release and PS exposure induced by both the thrombin receptor and GPVI signaling pathways. Interestingly, U46619 or ADP failed to induce observable PS exposure and MV release even with shear (supplemental Figure 2 ).
Thus, it appears that platelet PS exposure and MV release are selective for certain platelet activation pathways. The agonist/shear-dependent platelet PS exposure and MV release also requires an important role of β3 integrins.
The role of Gα13-dependent integrin outside-in signaling in MV release and PS exposure
Ligand binding to integrins not only mediates platelet adhesion and aggregation, but also transmits outside-in signaling, which requires the interaction between Gα13 and the cytoplasmic domain of the integrin β3 subunit. To assess whether outside-in signaling is responsible for shear-dependent MV release and PS exposure, bone marrow stem cells from β3 -/mice were infected with lentivirus encoding the cDNA sequence of wild type or a Gα13 binding-deficient mutant (E 733 EE to AAA) of β3 (which is defective in outside-in signaling without affecting ligand binding 29 ), then transplanted to recipient integrin β3 -/mice after irradiation. Six weeks after transplantation, platelets from the recipient mice were analyzed for MV release and PS exposure. Thrombin-induced, shear-dependent MV release and PS exposure in β3 -/platelets was rescued by wild type β3 expression to 
Integrin αIIbβ3 serves as a mechanical force sensor in mediating PS exposure in activated platelets
To understand why integrin outside-in signaling is important in agonist-and shearinduced PS exposure and the release of PS-exposed MVs, we used a newly developed interrogation was first allowed to repeatedly touch the FN-conjugated force probe to engage and pull on αIIbβ3 at a defined frequency, and reoriented to repeatedly contact a second, annexin V-conjugated force probe to detect binding of the exposed PS. The frequency of resting platelet binding to the annexin V probe was near zero without prestimulation by pulling αIIbβ3 via FN, reflecting the fact that resting platelets minimally expose PS. Thrombin stimulation alone only moderately increased binding frequency ( Figure 5A ). In contrast, when a low number (1.6 per contact on average) of integrin αIIbβ3-fibronectin bonds was allowed to form on the platelet surface and force was applied to pull on these bonds, a marked further increase in annexin V binding frequency of thrombin-activated platelets was observed, indicating that pulling force applied through integrin-ligand interaction elicited a signal leading to exposure of PS ( Figure 5A ). This mechanically induced integrin signaling leading to PS exposure is likely the Gα13-dependent outside-in signal because the annexin V binding was reduced to the level of thrombin-stimulated platelets without the fibronectin interaction when platelets were pre-incubated with mP6, which inhibited Gα13-integrin interaction and outside-in signaling ( Figure 5A ), but not the scrambled peptide ( Figure 5A ). These data mechanistically explain why integrin signaling is important in shear force-dependent PS exposure, and suggest that by interacting with its ligands, integrin αIIbβ3 serves as a mechanical force sensor, converting the mechanical force to outside-in signaling, leading to PS exposure.
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The role of integrin outside-in signaling in promoting coagulation in vitro
To determine whether outside-in signaling-mediated PS exposure and MV release is important in coagulation, we measured the clotting time of citrated PRP following recalcification under the flow induced by stirring in vitro. Integrin β3 -/platelets suspended in human platelet-poor plasma (PPP) showed significantly longer clotting time than wild type platelets suspended in human PPP (Figure 5 B) . Strikingly, incubation of citrated human PRP or mouse platelet-containing plasma with mP6, but not its negative control peptide mP6Scr, also delayed the occurrence of coagulation under flow conditions induced by stirring or under high shear (6000 s -1 ) (Figure 5 C,D) .
Thus, integrin outside-in signaling is important in promoting coagulation.
The role of integrin outside-in signaling in promoting fibrin formation in vivo
To assess the role of outside-in signaling in fibrin formation in vivo, we investigated the effect of an outside-in signal inhibitor, mP6 29 , on thrombus formation in a laser-induced cremaster arteriolar thrombosis model. Under our experimental conditions (laser intensity is sufficient for endothelial injury, but not for burning large holes in blood vessels), platelet thrombi formed rapidly at the site of arteriolar wall injury but the thrombus size rapidly decreased after peaking at ~2 minutes. Fibrin formation, however, showed a significant delay and followed platelet thrombus formation. In addition to the major intravascular fibrin formation at the site of laser-induced injury ( Figure 6 ) that expanded into the lumen, we also observed occasional fibrin formation located outside For personal use only. on June 2, 2018. by guest www.bloodjournal.org From the vessel lumen near the injury sites. The extravascular fibrin formation appeared to be independent of the bulk of the intravascular platelet thrombus (see Movie 2) , which is consistent with the knowledge that tissue factor and PS can be provided by many types of cells/tissues 47, 48 . However, the intravascular fibrin formed was associated with platelet thrombi and stabilization of platelet thrombi (Figure 6 A, B) . The sizes of the fibrin clot and platelet thrombus were both inhibited in mice treated with mP6 but not scrambled control peptide (Figure 6 C, D) . To exclude possible off-target effects of mP6, we also examined intravascular platelet thrombus and fibrin formation in platelet-specific Gα13 knockout mice (Gα13 fl/fl -PF4-cre), as compared to wild type control from the same genetic background (Gα13 fl/fl ) using the laser-induced cremaster arteriolar thrombosis model. Mice deficient in platelet Gα13 showed a dramatic inhibition in both fibrin formation and platelet thrombus size as compared to control mice (Figure 7) , which mirrored the effect of mP6. Thus, our data suggest that Gα13-dependent outside-in signaling of integrin αIIbβ3 is important for intravascular fibrin clot formation in vivo and, importantly, that selective inhibition of integrin outside-in signaling inhibits not only platelet thrombus formation but also intravascular fibrin clot formation in vivo.
Discussion
In this study, we made a significant advance in our understanding of the mechanism that regulates the procoagulant response of platelets to shear. We demonstrate that integrin αIIbβ3 serves as a mechanical sensor that transduces mechanical force into outside-in signals, which, via a Gα13, Src and Rac1-dependent signaling pathway, leads
For personal use only. on June 2, 2018. by guest www.bloodjournal.org From to PS exposure and PS-exposed MV release. This integrin outside-in signaling pathway is important for facilitating coagulation in vitro and intravascularly in vivo. Importantly, we show that a selective integrin outside-in signaling inhibitor is potently anti-thrombotic, as it inhibits not only platelet thrombus expansion but also intravascular coagulation at the site of vascular injury.
Our discovery that integrin outside-in signaling is critically important for platelet PS exposure, MV release and procoagulant function is consistent with previous knowledge of the important roles for platelets and integrin αIIbβ3 in promoting coagulation. Despite numerous early evidences that platelets play a critical role in promoting coagulation, there have been recent controversies with regard to the roles of platelets and integrin αIIbβ3 in facilitating coagulation in vivo. Studies from two laboratories showed significant inhibitory effects of integrin antagonists on platelet thrombus formation but not on fibrin deposition at the site of vascular injury using the laser-induced mouse arteriolar thrombosis model 9, 10 . However, another study from one of the above-mentioned laboratories, using the same technology, demonstrated defective platelet thrombus formation and fibrin clot formation in integrin β3 knockout mice 44 . In analyzing these apparently contradictory results, we noted two major differences. First, the studies by Cho et al 44 used limited laser power/duration that was sufficient to injure the endothelial cells causing thrombosis, but insufficient to cause a major penetrating hole in the blood vessel. The laser power used in some other studies, however, caused a more severe penetrating injury, with fibrin located primarily outside of the vascular lumen 9 . Thus, platelets are required to provide sufficient PS surface for intra-lumen coagulation, but
For personal use only. on June 2, 2018. by guest www.bloodjournal.org From coagulation may also be facilitated by PS provided by cells on or outside of the blood vessel wall. Second, the studies showing ineffective inhibition of fibrin clot formation by integrin inhibitors and PAR4 antagonists also showed only partial inhibition of platelet thrombus formation 9,10 , whereas studies using the β3 knockout mice completely inhibited platelet thrombus formation as expected for total lack of this receptor 44 . Considering the vast reserve capacity of platelets in PPA 3 , it is likely that the remaining platelet activation and integrin ligation following partial inhibition is already sufficient to transmit integrin outside-in signaling, leading to the induction of PPA. When the signaling molecules important for integrin outside-in signaling are inhibited, such as in the case of inhibition of Gα13-integrin interaction reported here, we have observed significantly diminished PPA without inhibiting the ligand binding function of integrins per se. Thus, combining previous controversies and the current data, it is clear that integrin outside-in signaling, but not the ligand binding function of integrin αIIbβ3 or its activation per se, is important for PPA in vivo intravascularly. Furthermore, we demonstrate that integrin αIIbβ3 functions as a mechanical force sensor triggering a Gα13/Src-dependent signaling pathway that cooperates with agonist receptor signaling pathways to induce PS exposure and the release of PS-exposed MVs, which are important for intravascular coagulation. However, we do not exclude the possibility that other conditions of platelet activation might be discovered to replicate or substitute for shear-induced integrin signaling even though we are not aware of what these conditions are at the present time.
For personal use only. on June 2, 2018. by guest www.bloodjournal.org From Platelets have two distinct adhesion receptor families that are known to be important in platelet adhesion under shear stress: the platelet vWF receptor, GPIb-IX, and integrins.
GPIb-IX has been previously reported to mediate platelet microparticle formation induced by shear stress, although at much higher shear stress than we applied, and GPIb-IX-dependent shear-stress-induced microparticle (microvesicle) release does not require stimulation by other agonists 49, 50 . Our study clearly shows that physiological levels of shear stress alone is not sufficient to induce microvesiculation nor PS exposure. Instead, agonist stimulation and β3 integrin is both required for platelet PS exposure and MV release. Importantly, we have directly demonstrated, at a molecular level, that integrin ligand-mediated pulling force induces mechanical signal transduction via the Gα13-dependent integrin outside-in signaling pathway, leading to PS exposure. This discovery is not only significant to elucidate the mechanisms of PPA induction but also to integrin-mediated mechanical signaling in other types of vascular cells with quite similar integrin outside-in signaling mechanisms. These cells, such as leukocytes and vascular endothelial cells, are exposed to shear stress of blood flow and release PSpositive MVs during activation, inflammation and injury. It would be interesting to further investigate whether similar mechanisms of activation of PS exposure and MV release occurs in these cells. For personal use only. on June 2, 2018. by guest www.bloodjournal.org From TMEM16F in PS exposure and MV release 1, 5, 51 . Because integrin ligation is known to induce cytoplasmic calcium elevation 52,53 , it is possible that shear/outside-in signaling greatly elevates cytoplasmic calcium to the level that is not otherwise achieved by the agonist receptor signaling pathways. Thus, it is tempting to hypothesize that sheardependent integrin outside-in signaling serves as physiological "calcium ionophore", greatly elevating cytoplasmic calcium following agonist stimulation, inducing PS exposure and MV release. However, PS exposure and MV release appear to be agonist-selective. TXA2 analog, U46619, a potent platelet agonist that stimulates robust calcium elevation, does not appear to induce significant PS exposure and microvesiculation. Also, integrin deficiency reportedly only affects calcium influx induced by low-dose thrombin, but not high-dose thrombin 52 . Furthermore, shear not only promotes platelet PS exposure and microvesiculation induced by physiological agonists, but also greatly enhanced PS exposure and MV release induced by calcium ionophore A23187 8 . Thus, it is possible that shear/integrin-dependent PS exposure and microvesiculation may also involve mechanisms other than calcium elevation. In any case, integrin outside-in signaling serves as an important physiological facilitator of platelet PS exposure, microvesiculation and PPA, and its downstream mechanisms warrant in-depth further investigation.
The discovery of an important role for integrin outside-in signaling in platelet PS exposure and MV release is significant not only to our understanding of the mechanisms that regulate PPA, but also has important implications in anti-platelet drug development. Recent studies indicate that selective targeting of integrin outside-in For personal use only. on June 2, 2018. by guest www.bloodjournal.org From signaling as a new anti-thrombotic strategy has the advantage of potently inhibiting occlusive platelet thrombus expansion without causing excessive bleeding 29 . This study further indicates that selective inhibition of integrin outside-in signaling not only inhibits platelet thrombus expansion, but also inhibits intravascular fibrin clot formation. This is significant, particularly in view of the data that partial inhibition of platelet thrombus formation by platelet activation inhibitors or by integrin inhibitors are not effective in inhibiting fibrin clot formation 9,10 , whereas complete inhibition of integrin ligand binding function is likely to cause excessive bleeding. Our work suggests that, by targeting integrin outside-in signaling without blocking platelet adhesion and primary aggregation, it is possible to diminish platelet-dependent intravascular fibrin clot without causing excessive bleeding. Because the intravascular fibrin clot around the platelet thrombus is associated with thrombus expansion and stabilization, this novel effect of outside-in signaling inhibitors is likely to contribute to the potency and anti-clotting effect of these new drugs, and is advantageous over the current anti-platelet drugs.
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